semaglutide and heart failure in Patients with Obesity-Related Type 2 Diabetes Semaglutide and tirzepatide both cut

WHAT BENEFITS DOES IT PROVIDE

Do not use Zepbound if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Obesity pharmacotherapy from the @TheAACE diabetes algorithm: GLP1/GIP and GLP1 RAs produce ~1020% weight loss with A1c reduction, while older agents like phentermine, orlistat, and naltrexone/bupropion have less efficacy and safety tradeoffs

Factors such as hormonal imbalances, insulin resistance, poor sleep, chronic stress, or certain prescription medications can all affect your ability to lose weight

In the same study, people using both the pill form and the injectable form of GLP-1s experienced frequent gastrointestinal adverse events